Published in Cancer Weekly, May 21st, 2002
TRA-8 is a monoclonal antibody that functions by binding to a specific site on the surface of a cancer cell, called death receptor 5 (DR5), triggering a cascade of enzymes that result in tumor...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2002-05-21)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.